Stock BIOCQ BIOCEPT, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Biocept, Inc.

Equities

BIOCQ

US09072V6002

Delayed OTC Markets
Other stock markets
 01:59:20 2024-05-31 pm EDT 		5-day change 1st Jan Change
0.0001 USD -.--% Intraday chart for Biocept, Inc. -.--% -99.76%
Apr. 26 Motion for Asset Sale Approved for Biocept, Inc. CI
Apr. 02 Motion for Asset Sale Approved for Biocept, Inc. CI

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Wall Street Set to Open Flat Friday as Investors Remain Wary of Potential Interest Rate Hike
MT
Maxim Group Downgrades Biocept to Hold From Buy
MT
Maxim Group Adjusts Biocept Price Target to $4 From $5, Maintains Buy Rating
MT
Maxim Group Adjusts Biocept Price Target to $7 From $12, Maintains Buy Rating
MT
BIOCEPT : Brookline Capital Assumes Coverage on Biocept With Buy Rating, $14 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIOCQ Stock
  4. News Biocept, Inc.
  5. Analyst Reco.